1. Home
  2. Labeler Index
  3. Ncs Healthcare Of Ky, Llc Dba Vangard Labs
  4. 0615-8153
  5. NDC Package Code: 0615-8153-39 Oxcarbazepine

NDC Package 0615-8153-39 Oxcarbazepine

Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0615-8153-39
Package Description:
30 TABLET, FILM COATED in 1 BLISTER PACK
Product Code:
0615-8153
Proprietary Name:
Oxcarbazepine
Non-Proprietary Name:
Oxcarbazepine
Substance Name:
Oxcarbazepine
Usage Information:
Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).
11-Digit NDC Billing Format:
00615815339
NDC to RxNorm Crosswalk:
  • RxCUI: 312136 - OXcarbazepine 150 MG Oral Tablet
  • RxCUI: 312136 - oxcarbazepine 150 MG Oral Tablet
  • RxCUI: 312137 - OXcarbazepine 300 MG Oral Tablet
  • RxCUI: 312137 - oxcarbazepine 300 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ncs Healthcare Of Ky, Llc Dba Vangard Labs
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • OXCARBAZEPINE 150 mg/1
    • Pharmacologic Class(es):
  • Anti-epileptic Agent - [EPC] (Established Pharmacologic Class)
  • Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    ANDA077794
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-09-2007
    End Marketing Date:
    04-30-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0615-8153-39?

    The NDC Packaged Code 0615-8153-39 is assigned to a package of 30 tablet, film coated in 1 blister pack of Oxcarbazepine, a human prescription drug labeled by Ncs Healthcare Of Ky, Llc Dba Vangard Labs. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 0615-8153 included in the NDC Directory?

    Yes, Oxcarbazepine with product code 0615-8153 is active and included in the NDC Directory. The product was first marketed by Ncs Healthcare Of Ky, Llc Dba Vangard Labs on October 09, 2007.

    What is the 11-digit format for NDC 0615-8153-39?

    The 11-digit format is 00615815339. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20615-8153-395-4-200615-8153-39